{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:19:58Z","timestamp":1780989598865,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.soc.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T01:57:21Z","timestamp":1634695041000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Disparities in the Management of Peritoneal Surface Malignancies"],"prefix":"10.1016","volume":"31","author":[{"given":"Kathleen","family":"Marulanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugwuji N.","family":"Maduekwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.soc.2021.07.005_bib1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1634\/theoncologist.2017-0081","article-title":"Appendiceal mucinous neoplasms: diagnosis and management","volume":"22","author":"Shaib","year":"2017","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.soc.2021.07.005_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4240\/wjgs.v10.i5.49","article-title":"Approach to pseudomyxoma peritonei","volume":"10","author":"Rizvi","year":"2018","journal-title":"World J Gastrointest Surg"},{"key":"10.1016\/j.soc.2021.07.005_bib3","series-title":"Guidelines for ovarian cancer (version 1.2019, March 8, 2019)","year":"2019"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/codi.13593","article-title":"Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines","volume":"19","author":"Klaver","year":"2017","journal-title":"Colorectal Dis"},{"issue":"6","key":"10.1016\/j.soc.2021.07.005_bib5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1245\/s10434-020-08316-w","article-title":"The Chicago Consensus on Peritoneal Surface Malignancies: management of appendiceal neoplasms","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.soc.2021.07.005_bib6","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","article-title":"8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer","volume":"15","author":"Verwaal","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"10.1016\/j.soc.2021.07.005_bib7","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1200\/JCO.2003.04.187","article-title":"Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer","volume":"21","author":"Verwaal","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1245\/s10434-019-07492-8","article-title":"Utilization and treatment patterns of cytoreduction surgery and intraperitoneal chemotherapy in the United States","volume":"27","author":"Ellis","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.21037\/jgo.2018.04.05","article-title":"Outcome and factors associated with aborted cytoreduction for peritoneal carcinomatosis","volume":"9","author":"Guerrero","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"issue":"26","key":"10.1016\/j.soc.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"26","key":"10.1016\/j.soc.2021.07.005_bib14","doi-asserted-by":"crossref","first-page":"43481","DOI":"10.18632\/oncotarget.16480","article-title":"Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy","volume":"8","author":"McMullen","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib15","doi-asserted-by":"crossref","first-page":"e266","DOI":"10.3747\/co.23.2831","article-title":"Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives","volume":"23","author":"Spiliotis","year":"2016","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.07.005_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","article-title":"Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy","volume":"27","author":"Witkamp","year":"2001","journal-title":"Cancer Treat Rev"},{"issue":"16","key":"10.1016\/j.soc.2021.07.005_bib17","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1002\/cncr.25116","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis","volume":"116","author":"Franko","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2021.07.005_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4613-1245-1_13","article-title":"Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy","volume":"81","author":"Sugarbaker","year":"1996","journal-title":"Cancer Treat Res"},{"issue":"11","key":"10.1016\/j.soc.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/cncr.32825","article-title":"The Chicago Consensus on peritoneal surface malignancies: Standards","volume":"126","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3390\/diagnostics10010043","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"10","author":"Riggs","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jso.20932","article-title":"Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United States","volume":"97","author":"Chan","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.soc.2021.07.005_bib22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/AOG.0b013e3182a92011","article-title":"Racial disparities in the treatment of advanced epithelial ovarian cancer","volume":"122","author":"Howell","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ygyno.2011.11.025","article-title":"Have racial disparities in ovarian cancer increased over time? An analysis of SEER data","volume":"125","author":"Terplan","year":"2012","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.soc.2021.07.005_bib24","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/cncr.10415","article-title":"Ethnic differences in survival among women with ovarian carcinoma","volume":"94","author":"Barnholtz-Sloan","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2021.07.005_bib25","series-title":"SEER cancer Statistics review, 1973-1994","year":"1997"},{"key":"10.1016\/j.soc.2021.07.005_bib26","series-title":"Ovarian Cancer Studies Aim to Reduce Racial Disparities, Improve Outcomes","year":"2020"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib27","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/IGC.0000000000001238","article-title":"Racial differences in survival from epithelial ovarian cancer are associated with stage at diagnosis and use of neoadjuvant therapy: a 10-year single-institution experience with a racially diverse urban population","volume":"28","author":"Miller","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib28","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/(SICI)1097-0142(19970815)80:4<816::AID-CNCR21>3.0.CO;2-V","article-title":"The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women","volume":"80","author":"Parham","year":"1997","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.socscimed.2010.03.033","article-title":"Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach","volume":"71","author":"Kim","year":"2010","journal-title":"Soc Sci Med"},{"issue":"6","key":"10.1016\/j.soc.2021.07.005_bib30","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-08-2902","article-title":"Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer","volume":"69","author":"Schildkraut","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/1055-9965.EPI-06-0868","article-title":"Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer","volume":"16","author":"Schildkraut","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2017.02.025","article-title":"Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?","volume":"145","author":"Ross","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ygyno.2011.04.047","article-title":"Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center","volume":"122","author":"Bristow","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","article-title":"Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades","volume":"189","author":"Barnholtz-Sloan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/annonc\/mdu534","article-title":"Incidence and determinants of 1-month mortality after cancer-directed surgery","volume":"26","author":"Mahal","year":"2015","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0b013e31822a6d56","article-title":"Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly","volume":"118","author":"Thrall","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.soc.2021.07.005_bib38","first-page":"1139","article-title":"Race in ovarian cancer treatment and survival: a systematic review with meta-analysis","volume":"20","author":"Terplan","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"22","key":"10.1016\/j.soc.2021.07.005_bib39","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/jnci\/91.22.1908","article-title":"Race and outcomes: is this the end of the beginning for minority health research?","volume":"91","author":"Brawley","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib40","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ijgc-00009577-200807000-00010","article-title":"Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer","volume":"18","author":"Du","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"18","key":"10.1016\/j.soc.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1002\/cncr.24482","article-title":"Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin\/paclitaxel: an analysis of Gynecologic Oncology Group trials","volume":"115","author":"Farley","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2008.08.013","article-title":"Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer","volume":"111","author":"Terplan","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2011.03.022","article-title":"Trends in treatment of advanced epithelial ovarian cancer in the Medicare population","volume":"122","author":"Thrall","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/AOG.0000000000000643","article-title":"Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines","volume":"125","author":"Bristow","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2014.02.006","article-title":"Reasons for failure to deliver National Comprehensive Cancer Network (NCCN)-adherent care in the treatment of epithelial ovarian cancer at an NCCN cancer center","volume":"133","author":"Erickson","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"20","key":"10.1016\/j.soc.2021.07.005_bib46","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1002\/cncr.25242","article-title":"Regional variation in cancer-directed surgery and mortality among women with epithelial ovarian cancer in the Medicare population","volume":"116","author":"Fairfield","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2014.08.029","article-title":"The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago","volume":"135","author":"Joslin","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.soc.2021.07.005_bib48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2010.12.347","article-title":"Racial disparities in ovarian cancer surgical care: a population-based analysis","volume":"121","author":"Bristow","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"18","key":"10.1016\/j.soc.2021.07.005_bib49","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1200\/JCO.2003.01.061","article-title":"Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States","volume":"21","author":"Harlan","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2021.07.005_bib50","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/cncr.22604","article-title":"Predictors of comprehensive surgical treatment in patients with ovarian cancer","volume":"109","author":"Goff","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients","volume":"98","author":"Earle","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.soc.2021.07.005_bib52","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/jnci\/djj018","article-title":"Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection","volume":"98","author":"Schrag","year":"2006","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib53","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2017.10.038","article-title":"Factors associated with delivery of neoadjuvant chemotherapy in women with advanced stage ovarian cancer","volume":"148","author":"Hinchcliff","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib54","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11605-014-2726-7","article-title":"The Rise in appendiceal cancer incidence: 2000-2009","volume":"19","author":"Marmor","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib55","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1053\/j.gastro.2020.06.011","article-title":"Early-onset appendiceal cancer survival by race or ethnicity in the United States","volume":"159","author":"Holowatyj","year":"2020","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.soc.2021.07.005_bib56","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00384-019-03387-y","article-title":"Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study","volume":"34","author":"Mo","year":"2019","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.soc.2021.07.005_bib57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jss.2019.01.039","article-title":"Who undergoes cytoreductive surgery and perioperative intraperitoneal chemotherapy for appendiceal cancer? An analysis of the National Cancer Database","volume":"238","author":"Byrne","year":"2019","journal-title":"J\u00a0Surg Res"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib58","doi-asserted-by":"crossref","first-page":"e0250726","DOI":"10.1371\/journal.pone.0250726","article-title":"Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer","volume":"16","author":"Rozich","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.soc.2021.07.005_bib59","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1245\/s10434-014-4220-6","article-title":"Escalation of socioeconomic disparities among patients with colorectal cancer receiving advanced surgical treatment","volume":"22","author":"Tabrizian","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.soc.2021.07.005_bib60","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1245\/s10434-021-09627-2","article-title":"Impact of Socioeconomic Status on Presentation and Outcomes in Colorectal Peritoneal Metastases Following Cytoreduction and Chemoperfusion: Persistent Inequalities in Outcomes at a High-Volume Center","volume":"28","author":"Rieser","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib61","doi-asserted-by":"crossref","first-page":"20170025","DOI":"10.1515\/pp-2017-0025","article-title":"Practice patterns, attitudes, and knowledge among physicians regarding cytoreductive surgery and HIPEC for patients with peritoneal metastases","volume":"3","author":"Bernaiche","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"4","key":"10.1016\/j.soc.2021.07.005_bib62","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ije\/30.4.668","article-title":"Theories for social epidemiology in the 21st century: an ecosocial perspective","volume":"30","author":"Krieger","year":"2001","journal-title":"Int J Epidemiol"},{"issue":"10077","key":"10.1016\/j.soc.2021.07.005_bib63","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0140-6736(17)30571-8","article-title":"Population health in an era of rising income inequality: USA, 1980\u20132015","volume":"389","author":"Bor","year":"2017","journal-title":"Lancet"},{"issue":"10077","key":"10.1016\/j.soc.2021.07.005_bib64","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(17)30569-X","article-title":"Structural racism and health inequities in the USA: evidence and interventions","volume":"389","author":"Bailey","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.soc.2021.07.005_bib65","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ygyno.2017.10.002","article-title":"Investigating Black-White disparities in gynecologic oncology: Theories, conceptual models, and applications","volume":"149","author":"Doll","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.soc.2021.07.005_bib66","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/cncr.22561","article-title":"Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis","volume":"109","author":"Bristow","year":"2007","journal-title":"Cancer"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320721000673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320721000673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:37:36Z","timestamp":1762360656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320721000673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1055320721000673"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2021.07.005","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in the Management of Peritoneal Surface Malignancies","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}